Tag: drug pricing

A new round of Medicare drug price negotiations shows the impact of the Inflation Reduction Act while exposing an ongoing political fight over who deserves credit for lowering drug costs.

Senate HELP Minority report says 688 drug prices rose after Trump took office, with some cancer therapies now over $200,000 a year and a rare-disease drug jumping 1,555 percent; White House tariffs and the One Big Beautiful Bill Act could push costs higher still.

Analysts warn of price risks even as generics, U.S. facilities, and European caps could blunt the impact.

The president’s directive to lower prescription costs relies on voluntary compliance and vague rulemaking powers, leaving analysts and advocates questioning its efficacy.

Order pushes for four-year delay in Medicare price talks for most prescription drugs, echoing pharma lobby demands and risking higher costs for patients.

Following Boehringer Ingelheim's lead, AstraZeneca pledges affordable respiratory care in the U.S., sparking calls for industry-wide reform.

"In a fiery Senate showdown, Senator Bernie Sanders challenges Big Pharma on exorbitant U.S. drug prices, revealing the stark divide between profit margins and patient access to essential medications."

Florida's groundbreaking move: importing affordable medication from Canada. Big Pharma's pushback and the FDA's historic approval — a turning point in U.S. healthcare?

'Republicans told millions of Americans who use insulin to go to hell.'

"It's a very weak proposal" but "we're dealing with the power of PhRMA over the Congress," he said, taking aim at industry lobbyists.